Open access peer-reviewed Edited Volume

Neuropsychology of Dementia

Devendra Kumar

Dehradun Institute of Technology University

Dr. Devendra Kumar's research interest includes the Design, Devolvement, and Biological screening of Small molecules, Metal complexes, Peptides for the management of Alzheimer's disease, Fragile X Syndrome, and Tuberculosis. Dr. Kumar worked on Alzheimer's disease and developed CNS active small molecules such as Acetylcholine, Butyl choline, Beta-secretase 1, Matrix Metalloprotein-2 and 9 inhibitors, and NMDA receptor antagonist.

Co-editors:

Sushil Kumar Singh

Banaras Hindu University

Dr. Singh is an eminent scientist and teacher in the field of neurodegenerative disorders. He was the Principal Investigator in the Development of bioactive molecules as therapeutic agents for Alzheimer’s disease and screening of their toxicity; IIT (BHU), Varanasi, as well as the Principal Investigator in Design and synthesis, is of Matrix Metallo Proteinase (MMP -2 & 9) inhibitors as therapeutic agents for Alzheimer’s disease; DBT, New Delhi.

Ankit Ganeshpurkar

Bharati Vidyapeeth Deemed University

Dr. Ganeshpurkar's objective is to create a niche in the field of medicinal chemistry and drug design research with an emphasis on the use of computational tools and artificial intelligence in lead identification and optimization. His research interest is in silico drug designing, lead identification, and optimization as well as design, synthesis and biological evaluation of Novel leads for various pathophysiological conditions such as Alzheimer’s and other neurodegenerative diseases.

Covering

Cognition Neuronal Circuits Learning and Memories Memory Consolidation in Dementia Neuropsychological Tests Treatments New Therapeutic Tools Biologics Brain Areas and Cognition Neuropsychology Neurological Disorders Modern Therapeutic Trends

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

Dementia has become the leading neurological problem for human beings associated not only with the old population but newer generations as well. Various environmental and genetic factors are reported to be involved in the disease. This book hopes to comprise a detailed discussion on the relationship between different brain areas and cognition. Pathophysiology of dementia containing molecular mechanisms will be explained as well as the memory function that depends on the neuronal circuits among the different brain areas. Other neuronal circuits involved in memory, learning, and dementia will also be discussed. Mechanism of neuronal circuits involved in memory consolidation, the main neurological disorders associated with dementia, dementia screening, and its validation, along with neurophysiological tests, will be covered. Another aspect that this book hopes to cover is the modern therapeutic trends for the management of dementia. Biologics will be changing the therapeutic world of dementia in the near future. We aim to have a project that consists of various cutting-edge technologies that have been adopted for the treatment of dementia.

Publishing process

Book initiated and editor appointed

Date completed: April 1st 2022

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Approved chapters written in full and submitted

Deadline for full chapters: June 28th 2022

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: September 16th 2022

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: November 15th 2022

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Devendra Kumar

Dehradun Institute of Technology University

Dr. Devendra Kumar is an Assistant Professor in the Department of Pharmacy. Dr. Kumar did his Ph.D. in Pharmaceutical Sciences from the Indian Institute of Technology (Banaras Hindu University) and completed his postdoctoral research at the University of Texas, USA (2019-2021). His research interest includes Design, Devolvement, and Biological screening of Small molecules, Metal complexes, Peptides for the management of Alzheimer\'s disease, Fragile X Syndrome, and Tuberculosis. Dr. Kumar worked on Alzheimer\'s disease and developed CNS active small molecules such as Acetylcholine, Butyl choline, Beta-secretase 1, Matrix Metalloprotein-2 and 9 inhibitors, and NMDA receptor antagonist. Along with the Drug Discovery, he is also working on the Pathophysiology of Fragile X Syndrome. His work on the Fragile X Syndrome includes identification of spine abnormality and the role of Microglia. The study of Microglia-Neuron communication in genetically modified animals is his thrust area. He is also working on the gene-editing tools using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology and the development of Blood-Brain Barrier penetrating Polymers as a delivery vehicle for CRISPR molecules.

View profile

Book chapters authored 0

Books edited 0

Introducing your Author Service Manager

Mrs. Silvia Sabo

Ask a question
creativecommons
alpsp
cope
stm
ithenticate
crossref
doi
oaspa

Book will be abstracted and indexed in

googlescholar
worldcat
base
az
openaire